Cited by 1,573SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesViral gastroenteritis research and epidemiology

SARS-CoV-2 productively infects human gut enterocytes

Open access
Lamers, Mart M., Beumer, Joep, van der Vaart, Jelte, Knoops, Kèvin, Puschhof, Jens, Breugem, Tim I., Ravelli, Raimond B. G., Paul van Schayck, J. +13 more·2020·Science

Published version of a preprint

Abstract

Intestinal organoids as an infection model: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes an influenza-like disease with a respiratory transmission route; however, patients often present with gastrointestinal symptoms such as diarrhea, vomiting, and abdominal pain. Moreover, the virus has been detected in anal swabs, and cells in the inner-gut lining express the receptor that SARS-CoV-2 uses to gain entry to cells. Lamers et al. used human intestinal organoids, a “mini-gut” cultured in a dish, to demonstrate that SARS-CoV-2 readily replicates in an abundant cell type in the gut lining—the enterocyte—resulting in the production of large amounts of infective virus particles in the intestine. This work demonstrates that intestinal organoids can serve as a model to understand SARS-CoV-2 biology and infectivity in the gut. Science , this issue p. 50

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.abc1669

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Over 2,000 CFTR mutations have been reported, but small molecule therapeutics deployed clinically target only a subset of them.

    “Over 2,000 mutations have been reported, yet small molecule therapeutics deployed clinically only target a subset of these185,186.”

    From Organoids (2022) · cites this paper as [185]

    The retrieved passages from the References section (page unavailable) concern coronavirus research, not CFTR mutation counts or CFTR-targeted therapies. Searches for CFTR, cystic fibrosis, 2,000 mutations, and small-molecule therapeutics found no passage in our copy addressing either part of the claim. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • Cystic fibrosis is a genetic disorder caused by mutations in CFTR, which encodes a transmembrane chloride and bicarbonate transporter.

    “Cystic fibrosis (CF) is a genetic disorder caused by mutations in the gene CFTR, which expresses a transmembrane chloride and bicarbonate transporter.”

    From Organoids (2022) · cites this paper as [185]

    The supplied Abstract and the passages on airway and gut organoids address SARS-CoV-2 infection, not cystic fibrosis. Searches for CFTR, cystic fibrosis, and chloride and bicarbonate transport found no passage in our copy that addresses the attributed claim. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • Productive SARS-CoV-2 infection has been demonstrated in enterocyte organoids in vitro.

    “Productive infection has been demonstrated in enterocyte organoids in vitro (Lamers et al., 2020)”

    From Viral Infections, the Microbiome, and Probiotics (2021) · cites this paper as Lamers et al., 2020

  • Low level expression of ACE2 can support CoV-2 cell entry.

    “In addition, it has recently been reported that low level expression of ACE2 can support CoV-2 cell entry (86); it is possible, therefore, that ACE2 expression beneath the level of detection in our assays may yet enable CoV-2 infection of apparently ACE2 negative cell types.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lamers, M. M., Beumer, J., van der Vaart, J., Knoops, K., Puschhof, J., Breugem, T. I., Ravelli, R. B. G., Paul van Schayck, J., Mykytyn, A. Z., Duimel, H. Q., van Donselaar, E., Riesebosch, S., Kuijpers, H. J. H., Schipper, D., van de Wetering, W. J., de Graaf, M., Koopmans, M., Cuppen, E., Peters, P. J., Haagmans, B. L., & Clevers, H.
Affiliations
  • Erasmus MC (NL)
  • Royal Netherlands Academy of Arts and Sciences (NL)
  • Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center, Utrecht, Netherlands.
  • Maastricht University (NL)
  • The Maastricht Multimodal Molecular Imaging Institute, Maastricht University, Maastricht, Netherlands.
  • Viroscience Department, Erasmus Medical Center, Rotterdam, Netherlands.
  • University Medical Center Utrecht (NL)
Corresponding author
  • Lamers, Mart M.
  • Beumer, Joep
  • Haagmans, Bart L.
  • Clevers, Hans
Venue
Science
Published
2020-07-03
Volume
369
Issue
6499
Pages
50-54
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W3020909574
Cited by
1,573
References
51
Citations by year
2026: 62 · 2025: 79 · 2024: 120 · 2023: 194 · 2022: 286 · 2021: 476 · 2020: 353 · 2018: 1 · 2017: 1
FWCI
42.97
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Science (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion, other-oa)
  • Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • European Research Council (67013)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (022.005.032, 184.034.019 (X-omics))
  • Dutch Technology Foundation STW (14207)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
Keywords
SARS-CoV-2, COVID-19 pandemic, enterocytes, intestinal epithelium, ACE2 receptor, small intestinal organoids, viral replication, viral shedding, experimental infection model
MeSH terms
Betacoronavirus, Angiotensin-Converting Enzyme 2, SARS-CoV-2, Cell Differentiation, Culture Media, Humans, Ileum, Peptidyl-Dipeptidase A, Lung, Male, Organoids, Receptors, Virus, RNA, Messenger, Virus Replication, Gene Expression, Cell Culture Techniques, Cell Lineage, Respiratory Mucosa, Enterocytes, Severe acute respiratory syndrome-related coronavirus, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review